当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析

九洲药业

(603456)

  

流通市值:184.38亿  总市值:184.38亿
流通股本:8.89亿   总股本:8.89亿

九洲药业(603456)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润7.49亿元,每股收益0.84元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益882420.92万元,未分配利润333926.35万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1071873.75万元,负债189452.83万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入4,160,487,725.652,870,947,333.221,490,269,186.295,160,584,725.38
营业总成本3,195,334,808.192,196,824,757.621,154,593,465.074,227,810,994.3
其他经营收益
营业利润912,351,045.88653,590,597.69311,409,338.37732,186,453.85
利润总额909,807,395.65650,314,797.16310,520,348.35730,602,422.01
净利润748,674,344.04526,613,903.71249,898,291.04607,067,516.83
每股收益
其他综合收益3,761,640.597,280,131.473,364,061.566,222,572.26
综合收益总额752,435,984.63533,894,035.18253,262,352.6613,290,089.09
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计5,518,729,793.695,814,592,964.265,968,483,213.116,071,494,807.15
非流动资产:
非流动资产合计5,200,007,694.165,140,507,903.475,062,445,998.325,055,759,255.69
资产总计10,718,737,487.8510,955,100,867.7311,030,929,211.4311,127,254,062.84
流动负债:
流动负债合计1,626,561,569.921,904,995,740.181,889,635,666.052,046,269,461.16
非流动负债:
非流动负债合计267,966,711.58270,842,005.4274,720,708.4471,401,782.01
负债合计1,894,528,281.52,175,837,745.582,164,356,374.452,517,671,243.17
所有者权益(或股东权益):
归属于母公司股东权益合计8,755,178,673.488,710,471,563.768,793,968,501.88,536,673,816.75
股东权益合计8,824,209,206.358,779,263,122.158,866,572,836.988,609,582,819.67
负债和股东权益合计10,718,737,487.8510,955,100,867.7311,030,929,211.4311,127,254,062.84
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计4,725,571,418.113,119,108,184.611,525,911,369.15,005,650,456.64
经营活动现金流出小计3,383,566,378.622,273,960,0401,240,238,112.864,013,995,282.57
经营活动产生的现金流量净额1,342,005,039.49845,148,144.61285,673,256.24991,655,174.07
投资活动产生的现金流量:
投资活动现金流入小计5,822,915.534,749,630.812,559,322.3532,638,862.73
投资活动现金流出小计534,459,528.27387,285,184.8277,560,791.29913,964,773.75
投资活动产生的现金流量净额-528,636,612.74-382,535,553.99-275,001,468.94-881,325,911.02
筹资活动产生的现金流量:
筹资活动现金流入小计470,000,000300,000,000300,000,0001,927,052,534.16
筹资活动现金流出小计1,305,569,005.33673,808,894.79299,540,021.12,536,663,959.45
筹资活动产生的现金流量净额-835,569,005.33-373,808,894.79459,978.9-609,611,425.29
汇率变动对现金及现金等价物的影响-4,113,3554,568,061.654,137,864.9816,894,805.3
现金及现金等价物净增加额-26,313,933.5793,371,757.4915,269,631.18-482,387,356.94
期末现金及现金等价物余额2,567,368,061.392,687,053,752.452,608,951,626.142,593,681,994.96
补充资料:
现金及现金等价物的净增加额-93,371,757.49--482,387,356.94
最新报告期:2025-09-18
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国盛证券张金洋,胡偌碧1.071.171.332025-09-18
长城国瑞证券胡晨曦0.971.121.202025-08-12
西部证券徐子悦,李梦园1.031.221.292025-08-11
中信建投王云鹏,袁清慧,贺菊颖1.101.251.392025-08-10
招商证券梁广楷,许菲菲1.001.201.302025-08-07
TOP↑